Folate and Prograf drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Folate (folic acid) and Prograf (tacrolimus). Common drug interactions include gastrointestinal haemorrhage among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Folate and Prograf. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Folate?

Folate has active ingredients of folic acid. It is often used in rheumatoid arthritis. eHealthMe is studying from 6,546 Folate users. Check the latest studies of Folate.

What is Prograf?

Prograf has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 42,230 Prograf users. Check the latest studies of Prograf.



On Jul, 08, 2026

36 people who take Folate and Prograf together, and have interactions are studied.

Folate and Prograf drug interactions.

What are the common drug interactions of Folate and Prograf, by gender? *:

female:

  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Haemodialysis complication
  3. Haemorrhage (bleeding)
  4. Lip swelling
  5. Loss of consciousness
  6. Nervous system disorder (a general class of medical conditions affecting the nervous system)
  7. Pneumonia
  8. Renal failure acute (rapid kidney dysfunction)
  9. Road traffic accident
  10. Transplant rejection (a transplant material is not worked)

male:

  1. Renal failure (kidney dysfunction)
  2. Bacteraemia (presence of bacteria in the blood)
  3. Blood bilirubin increased
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  6. Burkholderia cepacia complex infection (complex infection by group of bacteria burkholderia cepacia -resistant to common antibiotics)
  7. Cholecystitis (infection of gallbladder)
  8. Cytomegalovirus infection
  9. Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function)
  10. Dyspepsia (indigestion)

What are the common drug interactions of Folate and Prograf, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Cardiac tamponade (fluid accumulates in heart covering)

30-39:

  1. Abdominal pain
  2. Bacteraemia (presence of bacteria in the blood)
  3. Burkholderia cepacia complex infection (complex infection by group of bacteria burkholderia cepacia -resistant to common antibiotics)
  4. Cholecystitis (infection of gallbladder)
  5. Death
  6. Dyspnoea (difficult or laboured respiration)
  7. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  8. Liver injury
  9. Nausea (feeling of having an urge to vomit)
  10. Pancreatitis (inflammation of pancreas)

40-49:

  1. Renal failure (kidney dysfunction)
  2. Chronic kidney disease
  3. Drug toxicity
  4. Hypertension (high blood pressure)
  5. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  6. Neck pain
  7. Nephrogenic anaemia (anaemia due to kidney disease)
  8. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  9. Air embolism
  10. Alcohol withdrawal syndrome

50-59:

  1. Appendicitis (inflammation of the appendix)
  2. Bacterial infection

60+:

  1. Accident
  2. Concussion (short loss of normal brain function in response to a head injury)
  3. Anaemia (lack of blood)
  4. Bacteraemia (presence of bacteria in the blood)
  5. Bk virus infection
  6. Blood bilirubin increased
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Cytomegalovirus infection
  9. Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function)
  10. Drug ineffective

What are the existing conditions these people have? *

  1. Depression: 11 people, 30.56%
  2. High Blood Cholesterol: 9 people, 25.00%
  3. Cardiac Disorder: 6 people, 16.67%
  4. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 6 people, 16.67%
  5. Swelling: 6 people, 16.67%
  6. Immune System Disorder: 5 people, 13.89%
  7. Blood Glucose Abnormal: 5 people, 13.89%
  8. Stress And Anxiety: 5 people, 13.89%
  9. Blood Pressure Abnormal: 5 people, 13.89%
  10. Hypersensitivity: 5 people, 13.89%

* Approximation only. Some reports may have incomplete information.

Do you take Folate and Prograf?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Folate and Prograf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Folate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prograf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Folate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prograf and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on folic acid and tacrolimus (the active ingredients of Folate and Prograf, respectively), and Folate and Prograf (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: